🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 45258J102
- Market Cap
- Large Cap
- Previous Symbol
- HSAC (changed 12/19/2019)
- Previous Name
- Health Sciences Acquisitions Corp
Business: Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Notes: December 19, 2019 -- Immunovant, Inc., formerly known as Health Sciences Acquisitions Corporation (Nasdaq: HSAC) (“HSAC”), a special purpose acquisition company sponsored by RTW Investments, LP, announced today the closing of its business combination with Immunovant Sciences Ltd. (“ISL”), a clinical stage biopharmaceutical company developing IMVT-1401, a fully human monoclonal antibody that selectively binds to and inhibits the neonatal Fc receptor (“FcRn”) and is designed to be delivered by subcutaneous injection.
Company Contact
- CEO
- Pete Salzmann
- CFO
- Renee Barnett
- Headquarters
- 320 West 37th Street New York, NY 10018
- Phone
- 917-580-3099
- Investor Relations
- Chau Cheng · 917-580-3099 · info@immunovant.com